Johnson & Johnson Analysis Projects Lower Impella Costs Than Balloon Pump
An analysis projects lower healthcare costs with Impella than with an intra-aortic balloon pump in patients with heart failure.
An analysis projects lower healthcare costs with Impella than with an intra-aortic balloon pump in patients with heart failure.